Investing in Johnson & Johnson.
Johnson & Johnson has been a part of people's lives for 128 years and a valuable part of their investments for approximately 70 years. Founded in 1886, we listed our shares on the New York Stock Exchange for public investors in 1944.
During our history, we have built the most comprehensive base of health care businesses in the world, generating approximately 70 percent of our revenues from No. 1 or No. 2 global leadership positions in our respective markets.
Our consistent performance has enabled us to deliver an exceptional track record of growth that few, if any, companies can claim: 30 consecutive years of adjusted earnings increases; and 52 consecutive years of dividend increases. Over the last 10 years, Johnson & Johnson stock generated a 8.9 percent total return for investors compared to a 7.4 percent total return for the S&P 500.(1)
September 15, 2014
FDA Approves New Styles Of The MENTOR® MemoryShape® Silicone Breast Implant
September 10, 2014
Cordis Corporation Launches INCRAFT® AAA Stent Graft System for Treatment of Abdominal Aortic Aneurysms (AAA)
September 4, 2014
Johnson & Johnson Responds to Ebola Crisis With Commitment to Accelerate Vaccine Program in Collaboration With the US National Institutes of Health (NIH) and Provide Humanitarian Relief Aid
September 10, 2014 at 9:45 AM
Johnson & Johnson at Morgan Stanley Global Healthcare Conference
Financial Quick Links
1. Data source - Bloomberg